The move suggests that the OxyContin maker is trying to reduce the visibility of a building that has been increasingly targeted by protesters, rather than a rebranding stint, according to the report.
The drugmaker had several company-branded markers at the front entrance and sidewalk around its headquarters. All have come down in the last few weeks. Purdue Pharma has not said if it will replace them.
Purdue Pharma is facing thousands of lawsuits claiming it helped fuel the opioid epidemic in the U.S.
Read the full report here.
More articles on pharmacy:
8 recent pharmaceutical lawsuits, settlements
McKesson renews distribution deal with CVS Health
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
